5th Ebola Fatality Confirmed in the DRC
The U.S. CDC recently reissued a Watch - Level 1, Practice Usual Precautions, travel advisory for the ongoing Ebola outbreak in the Mbandaka Health Zone of the Democratic Republic of the Congo (DRC).
The WHO Africa confirmed the fifth fatal Ebola case in the DRC on May 25, 2022.
On May 18, 2022, the CDC warned international travelers to this area they should avoid contact with sick people and all contact with blood and other body fluids from other people in Mbandaka.
Furthermore, travelers should seek medical care immediately if they develop fever, muscle pain, sore throat, diarrhea, weakness, vomiting, stomach pain, or unexplained bleeding or bruising during or after travel to the DRC for up to 21 days.
The WHO African Region recently confirmed this is the DRC's fourteenth Ebola outbreak since 1976.
A protective vaccine against Zaire ebolavirus is available to specific individuals in select occupations (first responders).
The WHO confirmed over 1,300 people had been recently vaccinated.
However, Merck's U.S. FDA-approved Ervebo (rVSVΔG-ZEBOV-GP) vaccine is not commercially available and can only be accessed through the CDC.
Ebola virus disease is a rare and deadly disease that periodically causes outbreaks in several African countries.
It is spread by contact with blood or body fluids of a person infected with the Ebola virus.
According to the CDC, it is also spread by contact with contaminated objects or infected animals.
Other Ebola vaccination news is posted at Vax-Before-Travel.com/Ebola.
The CDC previously issued Travel Notices for the DRC's polio, COVID-19, and monkeypox outbreaks.
Note: The CDC travel advisory was manually edited for mobile readership.